Antares Pharma to Present at the Raymond James Human Health Innovations Conference
EWING, N.J., June 15, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…
Month: June 2021
Agenus Announces Virtual Annual Shareholders Meeting
LEXINGTON, Mass., June 15, 2021 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with…
Agenus Announces Virtual Annual Shareholders Meeting
LEXINGTON, Mass., June 15, 2021 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with…
Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment
IBS is one of the most important gastrointestinal disorders in Mexico, with a prevalence of…
Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment
IBS is one of the most important gastrointestinal disorders in Mexico, with a prevalence of…
Palisade Bio Launches Clinical Steering Committee to Provide Clinical Oversight and Guide Preparation for Late-Stage Clinical Trials of LB1148 in Accelerating Postoperative Return of Bowel Function and Reduction of Post-Surgical Adhesions
Former Leading BioSciences Chairman and Retired Board-Certified Surgeon, Dr. David Berry to Serve as Chair…
Palisade Bio Launches Clinical Steering Committee to Provide Clinical Oversight and Guide Preparation for Late-Stage Clinical Trials of LB1148 in Accelerating Postoperative Return of Bowel Function and Reduction of Post-Surgical Adhesions
Former Leading BioSciences Chairman and Retired Board-Certified Surgeon, Dr. David Berry to Serve as Chair…
Akoya to Help Support Leading Philanthropic Organization with Spatial Phenotyping Capabilities
CODEX’s single-cell, multiplex imaging capabilities to be included in Chan Zuckerberg Initiative grantee toolkit to…
Akoya to Help Support Leading Philanthropic Organization with Spatial Phenotyping Capabilities
CODEX’s single-cell, multiplex imaging capabilities to be included in Chan Zuckerberg Initiative grantee toolkit to…
Intercept to Present at the Raymond James 2021 Human Health Innovation Conference
NEW YORK, June 15, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company…
Intercept to Present at the Raymond James 2021 Human Health Innovation Conference
NEW YORK, June 15, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company…
Kriya Therapeutics Strengthens Leadership Team with the Appointment of Dr. Ilise Lombardo as Chief Medical Officer
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., June 15, 2021 (GLOBE NEWSWIRE) — Kriya…
Kriya Therapeutics Strengthens Leadership Team with the Appointment of Dr. Ilise Lombardo as Chief Medical Officer
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., June 15, 2021 (GLOBE NEWSWIRE) — Kriya…
BetterLife Pharma to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th
VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
BetterLife Pharma to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th
VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
GBT Awards $450,000 in ACCEL Grants to Improve Access to Care in Sickle Cell Disease
SOUTH SAN FRANCISCO, Calif., June 15, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
GBT Awards $450,000 in ACCEL Grants to Improve Access to Care in Sickle Cell Disease
SOUTH SAN FRANCISCO, Calif., June 15, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
Codiak BioSciences Expands Executive Leadership
– Sriram Sathyanarayanan, Ph.D. promoted to Chief Scientific Officer – – Konstantin Konstantinov, Ph.D. named…
Codiak BioSciences Expands Executive Leadership
– Sriram Sathyanarayanan, Ph.D. promoted to Chief Scientific Officer – – Konstantin Konstantinov, Ph.D. named…
PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression
Potential for FDA 505(b)(2) regulatory pathway approval and FDA Fast Track designation Advancing Ketamine and…